Intranasal Neuropeptide Y
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Intranasal Neuropeptide Y, covering 2016-04-14 to 2019-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder [Phase 1, Phase 2]